Artificial Intelligence In Drug Discovery

Facts and opinions about machine learning for biomedical research
John Cassidy, CEO of Cambridge Cancer Genomics, on AI-Powered Disease Prediction for Oncology
Kristen Fortney, CEO of BioAge Labs, on AI for Aging Research
Sam Cooper, CEO of Phenomic AI, on Automated HCS and More
Shai Shen-Orr, Chief Scientist of CytoReason, on AI for Systems Immunology
Leila Pirhaji, CEO of ReviveMed, on AI for Metabolomics
Mostapha Benhenda of Startcrowd on AI Drug Discovery Hype
Mauro Cozzi, Co-founder of Researchably, on AI for Better Biomedical Search
Dekel Gelbman, CEO of FDNA, on "Next-Generation Phenotyping"
3 Ways Artificial Intelligence Can Improve Life Sciences e-Commerce
6 Things We Learned about Artificial Intelligence in Drug Discovery from 330 Scientists
28 Pharma Companies Using Artificial Intelligence in Drug Discovery
Take the Artificial Intelligence in Drug Discovery Survey

Never miss a blog post